Treatment modification after initiating second-line medication for type 2 diabetes. Liss DT, Cherupally M, O'Brien MJ, Kang RH, et al. Am J Manag Care 2023;29:661-668.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liss DT, Cherupally M, O'Brien MJ, Kang RH, et al. Treatment modification after initiating second-line medication for type 2 diabetes. Am J Manag Care 2023;29:661-668.
PMID: 38170483